- Norvasc update: FDA Law Blog reports that the district court has extended FDA’s deadline and that Zydus has filed a new citizen petition.
- Pharmalot reports on Barr Labs’ efforts to protect its Seasonale oral contraceptive from generic competition.
- The WSJ Health Blog summarizes today’s front-page WSJ article on Amgen’s recent troubles.
- The Business Standard and Times of India report that the Indian Health Minister has asked Novartis to withdraw its challenge of the Indian Patent Act, which follows India’s denial of a patent on Gleevec.
- Follow-on biologics: new PhRMA statement; NYT article; WSJ editorial.
Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Orange Book Blog 
Leave a comment